EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents

Doodipala Samba Reddy iD

The Journal of Pharmacology and Experimental Therapeutics · 2024

DOI: 10.1124/jpet.123.002040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024. Verfasst von Doodipala Samba Reddy. Beteiligte Einrichtung: Department of Neuroscience and Experimental Therapeutics, Texas A&M University School of Medicine and Institute of Pharmacology and Neurotherapeutics…. Hauptthemen laut MEDLINE: Medical Countermeasures, Terrorism. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Commentary delves into the current progress and challenges on ongoing research on medical countermeasures (MCs) for chemical, biologic, radiologic, and nuclear (CBRN) threats. CBRN agents pose a serious risk to human health and safety, with the potential for mass casualties in both military and civilian settings. Chemical threats are toxic compounds that could be used in a terrorist attack, an accidental release, or chemical warfare. They include nerve agents, organophosphates, pulmonary agents, metabolic/cellular agents, vesicants, ocular toxicants, and opioid agents. Developing effective MCs is crucial for mitigating the acute and chronic effects of exposure to CBRN agents. The papers in this special issue of JPET highlights the latest advancements in MC research, showcasing insightful outcomes on experimental models, mechanisms, and translational research on MCs for CBRN threats. They portray several notable contributions, including the development of neurosteroid and combination anticonvulsant therapies for nerve agent poisoning, the exploration of chronic impacts and diagnostic tracers for OP neurotoxicity, the establishment of innovative pediatric OP models, the identification of novel molecules for ocular, pulmonary and vesicant injuries, and the repurposing of existing drugs for the treatment of botulism, cyanide, and OP poisoning. These crucial outcomes underscore the breadth of current research covering a variety of chemical threats. Overall, this collection of articles highlights the importance of ongoing research and development in the field of MCs, emphasizing the potential of these countermeasures to effectively treat and mitigate the effects of toxicant exposures and thereby enhance our preparedness for mass casualty incidents. SIGNIFICANCE STATEMENT: CBRN agents pose a significant threat to public health. Effective MCs exist for certain chemical threats, but there is a need for new and improved MCs for many others. The research presented in this special issue of JPET highlights the latest advancements in MCs for CBRN threats. This research has the potential to lead to the development of new and repurposed MCs that are more effective, broad-spectrum, and easier to administer to mitigate acute and long-term consequences of chemical exposures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical CountermeasuresTerrorismHumansChild

Autor:innen und Institutionen

  • Department of Neuroscience and Experimental Therapeutics, Texas A&M University School of Medicine and Institute of Pharmacology and Neurotherapeutics, Texas A&M University Health Science Center, Bryan, Texas sambareddy@…

ORCID-Profile: Doodipala Samba Reddy

Förderung

  • NINDS NIH HHS

Zitieren

APA

Reddy, D. S. (2024). Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.123.002040

Vancouver

Reddy DS. Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents. The Journal of Pharmacology and Experimental Therapeutics. 2024. doi:10.1124/jpet.123.002040

BibTeX
@article{Reddy2024,
  author = {Reddy, Doodipala Samba},
  title = {Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2024},
  doi = {10.1124/jpet.123.002040}
}
Kostenlos starten →